Parkinson's disease: Cell Vulnerability and Disease Progression

Parkinson's disease: Cell Vulnerability and Disease Progression

Bibliographic Details
Main Authors:	Javier eBlesa, Jose L Lanciego, Jose A. eObeso
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2015-09-01
Series:	Frontiers in Neuroanatomy
Subjects:	Dopamine Parkinson Disease Substantia Nigra Striatum Vulnerability synuclein
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fnana.2015.00125/full

Similar Items

Habitual Behavior and Dopamine Cell Vulnerability in Parkinson´s Disease
by: Ledia eF. Hernandez, et al.
Published: (2015-08-01)

PARKINSON’S DISEASE: ANIMAL MODELS AND DOPAMINERGIC CELL VULNERABILITY
by: Javier eBlesa, et al.
Published: (2014-12-01)

Habitual behavior and dopamine cell vulnerability in Parkinson disease
by: Ledia eF. Hernandez, et al.
Published: (2015-11-01)

Parkinson's Disease Cell Vulnerability and Disease Progression
Published: (2015)

Oxidative stress and Parkinson’s Disease
by: Javier eBlesa, et al.
Published: (2015-07-01)

Past, present and future of the pathophysiological model of the basal ganglia
by: Jose A Obeso, et al.
Published: (2011-07-01)

Abnormal alpha-synuclein reduces nigral voltage-dependent anion channel 1 in sporadic and experimental Parkinson's disease
by: Yaping Chu, et al.
Published: (2014-09-01)

Molecular determinants of selective dopaminergic vulnerability in Parkinson’s disease: an update
by: Lars eBrichta, et al.
Published: (2014-12-01)

Oxidative Stress and Genetics in the Pathogenesis of Parkinson's Disease
by: Yi Zhang, et al.
Published: (2000-08-01)

Environmental Risk Factors and Parkinson's Disease: Selective Degeneration of Nigral Dopaminergic Neurons Caused by the Herbicide Paraquat
by: Alison L. McCormack, et al.
Published: (2002-07-01)

Increased vulnerability of nigrostriatal terminals in DJ-1-deficient mice is mediated by the dopamine transporter
by: Amy B. Manning-Boğ, et al.
Published: (2007-08-01)

A Multi-Scale Computational Model of Levodopa-Induced Toxicity in Parkinson's Disease
by: Chakravarthy, V.S, et al.
Published: (2022)

Age and α-synuclein expression interact to reveal a dependence of dopaminergic axons on endogenous Akt/PKB signaling
by: Sang Ryong Kim, et al.
Published: (2011-11-01)

Neuroprotective and Therapeutic Strategies against Parkinson’s Disease: Recent Perspectives
by: Sumit Sarkar, et al.
Published: (2016-06-01)

Inter-hemispheric asymmetry of nigrostriatal dopaminergic lesion. A possible compensatory mechanism in Parkinson’s disease
by: Javier eBlesa, et al.
Published: (2011-11-01)

Can Interactions Between α-Synuclein, Dopamine and Calcium Explain Selective Neurodegeneration in Parkinson's Disease?
by: Michael R. Post, et al.
Published: (2018-03-01)

Promising drug targets and associated therapeutic interventions in Parkinson’s disease
by: Sachchida Nand Rai, et al.
Published: (2021-01-01)

The Nigral Coup in Parkinson’s Disease by α-Synuclein and Its Associated Rebels
by: Jeswinder Sian-Hulsmann, et al.
Published: (2021-03-01)

Evidence for Dysfunction of the Nigrostriatal Pathway in the R6/1 Line of Transgenic Huntington's Disease Mice
by: Å. Petersén, et al.
Published: (2002-10-01)

Beyond reward prediction errors: the role of dopamine in movement kinematics
by: Joseph eBarter, et al.
Published: (2015-05-01)

AAV Vector-Mediated Gene Delivery to Substantia Nigra Dopamine Neurons: Implications for Gene Therapy and Disease Models
by: Katrina Albert, et al.
Published: (2017-02-01)

Widespread increases in malondialdehyde immunoreactivity in dopamine-rich and dopamine-poor regions of rat brain following multiple, high doses of methamphetamine.
by: Kristen Ashley eHorner, et al.
Published: (2011-05-01)

Cross-talk between mitochondria and proteasome in Parkinson's disease pathogenesis
by: Diogo Martins Branco, et al.
Published: (2010-05-01)

Amiloride is neuroprotective in an MPTP model of Parkinson's disease
by: Robert L. Arias, et al.
Published: (2008-09-01)

Arbutin effectively ameliorates the symptoms of Parkinson’s disease: the role of adenosine receptors and cyclic adenosine monophosphate
by: Jie Zhao, et al.
Published: (2021-01-01)

Minocycline restores striatal tyrosine hydroxylase in GDNF heterozygous mice but not in methamphetamine-treated mice
by: Heather A. Boger, et al.
Published: (2009-03-01)

Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: Diminished compensatory mechanisms as a prelude to parkinsonism
by: Timothy J. Collier, et al.
Published: (2007-04-01)

Transcriptional dysregulation in a transgenic model of Parkinson disease
by: Talene A. Yacoubian, et al.
Published: (2008-03-01)

Interactions between the midbrain superior colliculus and the basal ganglia
by: Peter eRedgrave, et al.
Published: (2010-09-01)

Cerebral Dopamine Neurotrophic Factor Diffuses Around the Brainstem and Does Not Undergo Anterograde Transport After Injection to the Substantia Nigra
by: Katrina Albert, et al.
Published: (2019-06-01)

Differential calcium dependence of axonal versus somatodendritic dopamine release, with characteristics of both in the ventral tegmental area
by: Billy T Chen, et al.
Published: (2011-06-01)

Transcranial sonography in Parkinson’s disease
by: I. V. Bayborodina, et al.
Published: (2018-03-01)

Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson's disease
by: Ariana Q. Farrand, et al.
Published: (2017-11-01)

Reduced complement of dopaminergic neurons in the substantia nigra pars compacta of mice with a constitutive “low footprint” genetic knockout of alpha-synuclein
by: Valeria V. Goloborshcheva, et al.
Published: (2020-05-01)

Chemical Exchange Saturation Transfer MR Imaging Is Superior to Diffusion Tensor Imaging in the Diagnosis and Severity Evaluation of Parkinson's Disease: a Study on Substantia Nigra and Striatum
by: Chunmei eLi, et al.
Published: (2015-10-01)

Involvement of GDNF in Neuronal Protection against 6-OHDA-Induced Parkinsonism Following Intracerebral Transplantation of Fetal Kidney Tissues in Adult Rats
by: C.V. Borlongan, et al.
Published: (2001-08-01)

To dopamine and beyond, a review of the mechanisms of Parkinson's disease
by: Chester, Andrew
Published: (2018)

Targeted Ablation of Primary Cilia in Differentiated Dopaminergic Neurons Reduces Striatal Dopamine and Responsiveness to Metabolic Stress
by: Rasem Mustafa, et al.
Published: (2021-08-01)

Integrating the Roles of Midbrain Dopamine Circuits in Behavior and Neuropsychiatric Disease
by: Allen PF Chen, et al.
Published: (2021-06-01)

Serotonergic neurons mediate ectopic release of dopamine induced by l-DOPA in a rat model of Parkinson's disease
by: Sylvia Navailles, et al.
Published: (2010-04-01)